Quality of the Systematic Reviews in Cochrane Gynecological Cancer Group and Their Understudied RCTs

Quality of the Systematic Reviews in Cochrane Gynecological Cancer Group and Their Understudied RCTs


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: سکینه حاج ابراهیمی , نوریه دلیراکبری , آرش حاجی کمانج علیا , سینا حسن نژاد , سارینا امینی زاده , فایزه درویشی , ریحانه حاج ابراهیمی , هانیه صالحی پورمهر

کلمات کلیدی:

نشریه: 21020 , S1 , 72 , 2022

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله هانیه صالحی پورمهر
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات پزشکی مبتنی بر شواهد EBM
کد مقاله 79091
عنوان فارسی مقاله Quality of the Systematic Reviews in Cochrane Gynecological Cancer Group and Their Understudied RCTs
عنوان لاتین مقاله Quality of the Systematic Reviews in Cochrane Gynecological Cancer Group and Their Understudied RCTs
ناشر 8
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Purpose Gynecological cancers are common neoplasms in clinical settings with a high impact on the economy of communities. The medical literature is an essential resource to guide clinical decision-making, and misconduct in researches undermines the credibility and integrity of research in general. We aimed to evaluate the quality of Cochrane gynecological cancers reviews and their understudies RCTS among the different biases dimensions. Methods This cross-sectional analytical study was performed on 118 systematic reviews published by the Cochrane gynecological cancers Group up to June 2021. The risk of bias was assessed in each Cochrane survey using the Joanna Bridges Institute (JBI) critical assessment tool consisting of 11 questions. The JBI checklist for systematic reviews and research syntheses is available at https://jbi.global/critical-appraisal-tools. After a systematic critical evaluation of the reviews and meta-analysis, we extracted a different bias from all of their understudied RCTs examined in these systematic reviews, which were evaluated by systematic review authors using a standard bias risk tool developed by the Cochrane Group. Results Cochrane gynecological cancers reviews had high quality based on appraise results using the JBI appraisal checklist. In addition, all of the included studies used PRISMA standards for reporting their results. However, in their understudied RCTs, the most prevalent risk of bias was unclear selection bias (allocation concealment) and performance bias (blinding of participants and personnel). Also, the highest risk of bias was blinding participants and personnel (performance bias) and incomplete outcome data (attrition bias). Our results showed that the lowest risk of bias was incomplete outcome data (attrition bias) and random sequence generation (selection bias). Conclusion Although most Cochrane gynecological cancers reviews had high quality, unclear performance bias was the highest in their understudied RCTs, indicating structural deficiencies.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
سکینه حاج ابراهیمیاول
نوریه دلیراکبریدوم
آرش حاجی کمانج علیاسوم
سینا حسن نژادچهارم
سارینا امینی زادهپنجم
فایزه درویشیششم
ریحانه حاج ابراهیمیهفتم
هانیه صالحی پورمهرهشتم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Quality of the Systematic Reviews in Cochrane Gynecological Cancer Group and Their Understudied RCTs _ SpringerLink.pdf1401/05/11238221دانلود